Overview

Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
Patients who undergo chemotherapy for leukemia will receive study medication for prevention of fungal infections. The study investigates the safety and tolerability of two different dosages, the efficacy in prevention of fungal diseases.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Basilea Pharmaceutica
Collaborator:
Basilea Pharmaceutica
Treatments:
Isavuconazole